Maintenance asthma treatment with fluticasone/salmeterol combination via diskus : Effect on outcomes in inner city children enrolled in TennCare - 25/08/11
Abstract |
Rationale |
Poor outcomes are well documented to be associated with inner city children with asthma. Our aim was to determine if therapy via Diskus (fluticasone/salmeterol [Advair 100 or 250]) inhaled twice daily would reduce emergency department (ED) visits, hospitalizations (HOSP), and HOSP days.
Methods |
For this pilot study, enrollment criteria were parent reported ≥5 ED visits in the last 2 years, ≥3 ED visits in the last year, or ≥2 HOSP for asthma in the last 2 years. Study patients were evaluated over 12 months, and served as their own controls; a separate control group of TennCare children not receiving Advair (but all prescribed inhaled corticosteroids) was included. ED visits and HOSP were assessed via childrens' hospital medical records.
Results |
Study patients (n=41; 31M, 10F, age range 8-17) had a mean 24% decrease in ED visits, which was significant (p=0.02) compared to control patients (n=40; 27M, 13F, age range 8-17). Both groups had significant reductions in HOSP and HOSP days.
Conclusion |
Results of this pilot study suggest that twice daily therapy with Advair Diskus is associated with reduced ED visits in inner city children with asthma enrolled in TennCare.
Le texte complet de cet article est disponible en PDF. | Funding: GSK |
Vol 113 - N° 2S
P. S276 - février 2004 Retour au numéro
Article précédent
- Specific airway conductance (SGaw) reflecting methacholine responsiveness is associated with BMI
- M.E. Rose, M.S. Kavuru, A.L. Melton, K. McCarthy, D.M. Lang
- Irreversible lung function deficits in young adults with a history of childhood asthma
- S.L. Limb, K. Brown, R.G. Hamilton, J. Tonascia, R. Wise, R. Wood, N.F. Adkinson
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?